These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8483021)

  • 1. Vascular effects of lacidipine: a review of animal and human data.
    Mancia G; Ferrari AU; Giannattasio C; Trazzi S
    J Hypertens Suppl; 1993 Mar; 11(1):S39-43. PubMed ID: 8483021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac and vascular effects of lacidipine.
    Agabiti-Rosei E
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S1-5. PubMed ID: 8852537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of calcium antagonists on the cardiovascular system: experience with lacidipine.
    Kuschnir E
    Drugs; 1999; 57 Suppl 1():11-7. PubMed ID: 10529078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart.
    Pijl AJ; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the vascular selectivity of lacidipine in the pithed rat.
    Micheli D; Massagrande M; Giacometti A; Collodel A; Gaviraghi G
    Pharmacology; 1992; 44(3):150-7. PubMed ID: 1579596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences between calcium antagonists: pharmacological aspects.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Mar; 11(1):S3-11. PubMed ID: 8483019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.
    Taddei S; Virdis A; Ghiadoni L; Uleri S; Magagna A; Salvetti A
    Hypertension; 1997 Dec; 30(6):1606-12. PubMed ID: 9403590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of lacidipine, a vascular-selective calcium antagonist.
    Micheli D; Ratti E; Toson G; Gaviraghi G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem.
    Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats.
    Krenek P; Salomone S; Kyselovic J; Wibo M; Morel N; Godfraind T
    Hypertension; 2001 Apr; 37(4):1124-8. PubMed ID: 11304513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of antihypertensive treatment on carotid vascular changes].
    Pompeo F; De Luca N; Marchegiano R; Gisonni P; Iovino G; D'Auria F; Del Mastro L; Simonelli P; Trimarco B
    Minerva Cardioangiol; 1994 Nov; 42(11):511-5. PubMed ID: 7700540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lacidipine on the carotid and cerebral circulations in essential hypertension.
    Safar ME
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S51-4. PubMed ID: 1726008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lacidipine on experimental models of atherosclerosis.
    Bernini F; Corsini A; Raiteri M; Soma MR; Paoletti R
    J Hypertens Suppl; 1993 Mar; 11(1):S61-6. PubMed ID: 8483025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that lacidipine at nonsustained antihypertensive doses activates nitrogen monoxide system in the endothelium of salt-loaded Dahl-S rats.
    Crespi F; Vecchiato E; Lazzarini C; Andreoli M; Gaviraghi G
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):471-7. PubMed ID: 11904520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.